Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

December 6, 2011

3 Tips on Valuations and Exits for Emerging Healthcare Companies

Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…

Posted by James A. Datin

November 23, 2011

A Focus on Life Sciences

Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…

Posted by James A. Datin

November 21, 2011

The Power of emPower!

PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…

Posted by James A. Datin

November 15, 2011

Opportunity in the Migraine Market for NuPathe

Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…

Posted by James A. Datin

November 11, 2011

Anatomy of a Deal: Advanced BioHealing

Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…

Posted by James A. Datin

November 8, 2011

The Developing Pet Generics Market: A Look at New Partner Company Putney

In America, there are more than 171 million dogs and cats in over 71 million households. Ninety-six percent of the drugs approved for these pets…

Posted by James A. Datin

June 27, 2011

Safeguard Scientifics Leads $35 Million Financing for NovaSom

Baltimore-based company provides home sleep tests for the diagnosis of obstructive sleep apnea Wayne, PA, June 27, 2011 – Safeguard Scientifics, Inc. (NYSE: SFE), a holding…

Posted by James A. Datin

January 19, 2011

Life Sciences Trends for 2011: Companion Diagnostics, Reimbursement and Consumerization

Last week, Safeguard Scientifics’ Life Sciences team attended J.P. Morgan’s 29th Annual Healthcare Conference and OneMedForumSF 2011 (video) in San Francisco. Our main takeaway is that…

Posted by James A. Datin

January 10, 2011

Discussing Life Sciences Trends at J.P. Morgan Healthcare Conference and OneMedForum

This week, our life sciences team is heading out to San Francisco to attend J.P. Morgan’s 29th Annual Healthcare Conference, one of the life science…

Posted by James A. Datin

Content